Nanologica's Rights Issue Registered - Conversion of BTA to Shares
Kurs
-4,13%
Likviditet
0,06 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-05-21 | N/A | Årsstämma |
| 2026-04-23 | 08:10 | Kvartalsrapport 2026-Q1 |
| 2026-02-12 | 08:10 | Bokslutskommuniké 2025 |
| 2025-10-23 | - | Kvartalsrapport 2025-Q3 |
| 2025-07-10 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-23 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2025-05-22 | - | Årsstämma |
| 2025-04-16 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-14 | - | Bokslutskommuniké 2024 |
| 2024-11-08 | - | Kvartalsrapport 2024-Q3 |
| 2024-09-23 | - | Extra Bolagsstämma 2024 |
| 2024-07-05 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2024-05-16 | - | Årsstämma |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-09 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-07 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-05 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2023-05-04 | - | Årsstämma |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-10 | - | Bokslutskommuniké 2022 |
| 2022-11-11 | - | Kvartalsrapport 2022-Q3 |
| 2022-09-15 | - | Extra Bolagsstämma 2022 |
| 2022-08-19 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-03 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2022-06-02 | - | Årsstämma |
| 2022-04-29 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-08 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-28 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2021-05-27 | - | Årsstämma |
| 2021-05-07 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-10-30 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-29 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2020-05-28 | - | Årsstämma |
| 2020-02-26 | - | Extra Bolagsstämma 2020 |
| 2020-02-24 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-07 | - | Bokslutskommuniké 2019 |
| 2019-10-25 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-27 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-31 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2019-05-29 | - | Årsstämma |
| 2019-05-10 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-15 | - | Bokslutskommuniké 2018 |
| 2018-11-23 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-23 | - | Kvartalsrapport 2018-Q2 |
| 2018-06-01 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2018-05-31 | - | Årsstämma |
| 2018-04-25 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-23 | - | Bokslutskommuniké 2017 |
| 2017-11-23 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-06-02 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2017-06-01 | - | Årsstämma |
| 2017-05-19 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Kvartalsrapport 2016-Q3 |
| 2016-09-12 | - | Extra Bolagsstämma 2016 |
| 2016-08-26 | - | Kvartalsrapport 2016-Q2 |
| 2016-06-01 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2016-05-31 | - | Årsstämma |
| 2016-05-20 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-19 | - | Bokslutskommuniké 2015 |
| 2015-11-26 | - | Kvartalsrapport 2015-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.
Nanologica AB’s (publ) rights issue of shares that ended on 13 March 2024 has been registered with the Swedish Companies Registration Office. The rights issue was subscribed to 100 percent leading to the company receiving MSEK 54,2 before issue costs and offsetting of loans.
The rights issue has been registered with the Swedish Companies Registration Office and the last day for trading in paid subscribed shares ("BTA") is 8 April 2024. The record date is 10 April 2024, after which the BTA is converted into shares. The newly issued shares are expected to be available in each shareholder's custody/securities account on 12 April 2024.
Through the rights issues, the number of shares in Nanologica increases by 8,032,476 shares from 36,146,142 shares to 44,178,618 shares, and the share capital increases by approximately SEK 3,293,538.36, from SEK 14,820,922.61 to SEK 18,114,460.97. The Extraordinary General Meeting on 22 February 2024 resolved to reduce the share capital by an amount in SEK corresponding to the amount by which the share capital increases through the rights issue. The effect of this decision is that the company's share capital does not increase in connection with the registration of the rights issue.
ISIN code for share in Nanologica, ticker NICA: SE0005454873
ISIN code for BTA in Nanologica, ticker NICA BTA: SE0021626900
For further information, please contact
Johanna Johansson
Director IR, Communications and Marketing
johanna.johansson@nanologica.com
+46 72 211 21 90
About Nanologica AB (publ)
Nanologica is a Swedish life science tools company that provides consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company's mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica's share (NICA) is listed for trading on Nasdaq Stockholm Main Market. For further information, please visit www.nanologica.com.